Dr Adil Daud is a nationally recognized expert in early phase drug development in skin cancer and solid tumors. He earned a medical degree at the Government Medical College in Nagpur, India. He completed an internship and residency in internal medicine at Indiana University Medical Center, followed by a fellowship in hematology-oncology at Memorial Sloan-Kettering Cancer Center.
Prior to joining UCSF Medical Center, he was Associate Professor and Director of the Affiliate Network at the Moffitt Cancer Center in Tampa, Fla. for seven years. Daud has won numerous awards, including the American Society for Clinical Oncology's Young Investigator award and Castle Connolly's Best Doctors in America award. He is an professor of medicine at UCSF.
Dr. Daud is Director of Melanoma Research at the UCSF Helen Diller Family Comprehensive Cancer Center. The programs goal is to better understand the biology of melanoma and develop new treatments for the disease. Daud has led numerous clinical trials that have expanded the use of targeted therapy for melanoma.